Correction to Lancet Diabetes Endocrinol 2023; 11: 414-25
- PMID: 37263283
- DOI: 10.1016/S2213-8587(23)00158-4
Correction to Lancet Diabetes Endocrinol 2023; 11: 414-25
Erratum for
-
Switching to once-weekly insulin icodec versus once-daily insulin degludec in individuals with basal insulin-treated type 2 diabetes (ONWARDS 2): a phase 3a, randomised, open label, multicentre, treat-to-target trial.Lancet Diabetes Endocrinol. 2023 Jun;11(6):414-425. doi: 10.1016/S2213-8587(23)00093-1. Epub 2023 May 3. Lancet Diabetes Endocrinol. 2023. PMID: 37148899 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
